(Q34845952)

PubMed publication ID

18836536

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18836536%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

1 reference

Leonard S Marks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

David G Bostwick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

publication date

1 January 2008

1 reference

PubMed publication ID

18836536

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18836536%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

page(s)

175-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

13 May 2020

cites work

1 reference

12 December 2020

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

1 reference

12 December 2020

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis

1 reference

12 December 2020

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer

1 reference

12 December 2020

PCA3: a molecular urine assay for predicting prostate biopsy outcome

1 reference

12 December 2020

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

12 December 2020

uPM3, a new molecular urine test for the detection of prostate cancer.

1 reference

12 December 2020

DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer

1 reference

12 December 2020

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

1 reference

12 December 2020

New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene

1 reference

12 December 2020

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

1 reference

12 December 2020

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

12 December 2020

Serial biopsy results in prostate cancer screening study

1 reference

12 December 2020

Clinical utility of prostate carcinoma molecular diagnostic tests.

1 reference

12 December 2020

Prostatitis and prostate cancer: implications for prostate cancer screening

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

12 December 2020

Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent

1 reference

12 December 2020

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

1 reference

12 December 2020

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

1 reference

12 December 2020

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

12 December 2020

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

1 reference

12 December 2020

Active surveillance with selective delayed intervention for favorable risk prostate cancer.

1 reference

12 December 2020

Words of wisdom. Re: PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. Whitman EJ, Groskopf J, Ali A, et al. J Urol 2008;180:1975-8; discussion 1978-9.

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC2556484&resulttype=core&format=json

13 May 2020

PubMed publication ID

18836536

1 reference